Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke

Neurosurgical Focus

Volumn 42, Issue 4, 2017, Pages

  Karsy, Michael ^a   Brock, Andrea ^a   Guan, Jian ^a   Taussky, Phillip ^a   Yashar S Kalani, M ^a   Park, Min S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrovascular accident; Intracerebral hemorrhage; Intraparenchymal hemorrhage; Neuroprotection; Stroke

Indexed keywords

NEUROPROTECTIVE AGENT;

ANIMAL; DRUG ADMINISTRATION ROUTE; GENETICS; HUMAN; MECHANICAL THROMBECTOMY; MOLECULAR BIOLOGY; PROCEDURES; STROKE;

ANIMALS; DRUG ADMINISTRATION ROUTES; HUMANS; MECHANICAL THROMBOLYSIS; MOLECULAR BIOLOGY; NEUROPROTECTIVE AGENTS; STROKE;

EID: 85016928437     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2017.1.FOCUS16522     Document Type: Article

References (161)

1. Aichner FT, Fazekas F, Brainin M, Pölz W, Mamoli B, Zeiler K: Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke 29:743-749, 1998
2. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM: Safety, tolerability, and pharmacokinetics of the N-methyld-aspartate antagonist dextrorphan in patients with acute stroke. Stroke 26:254-258, 1995
3. Albers GW, Goldstein LB, Hall D, Lesko LM: Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA 286:2673-2682, 2001
4. Amaro S, Laredo C, Renú A, Llull L, Rudilosso S, Obach V, et al: Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS Trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke). Stroke 47:2874-2876, 2016
5. Amaro S, Llull L, Renú A, Laredo C, Perez B, Vila E, et al: Uric acid improves glucose-driven oxidative stress in human ischemic stroke. Ann Neurol 77:775-783, 2015
6. Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M, et al: Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 516:125-130, 2005
7. American Nimodipine Study Group: Clinical trial of nimodipine in acute ischemic stroke. Stroke 23:3-8, 1992
8. Amiri-Nikpour MR, Nazarbaghi S, Hamdi-Holasou M, Rezaei Y: An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: genderdependent effect. Acta Neurol Scand 131:45-50, 2015
9. Argentino C, Sacchetti ML, Toni D, Savoini G, D'Arcangelo E, Erminio F, et al: GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study-Hemodilution + Drug. Stroke 20:1143-1149, 1989
10. Aronowski J, Zhao X: Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42:1781-1786, 2011
11. Arrich J, Holzer M, Havel C, Müllner M, Herkner H: Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2:CD004128, 2016
12. Arumugam TV, Granger DN, Mattson MP: Stroke and T-cells. Neuromolecular Med 7:229-242, 2005
13. Asadi B, Askari GR, Khorvash F, Bagherpur A, Mehrabi F, Karimi M, et al: Neuroprotective effects of erythropoietin in acute ischemic stroke. Int J Prev Med 4 (Suppl 2):S306-S312, 2013
14. Bath PM, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, Bereczki D, et al: Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partialfactorial randomised controlled trial. Lancet 385:617-628, 2015
15. Bordi F, Pietra C, Ziviani L, Reggiani A: The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Exp Neurol 145:425-433, 1997
16. Broughton BR, Reutens DC, Sobey CG: Apoptotic mechanisms after cerebral ischemia. Stroke 40:e331-e339, 2009
17. Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, et al: Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol 13:453-460, 2014
18. Chen X, Wang K: The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015 Acta Pharm Sin B 6:522-530, 2016
19. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA: A randomized dose-response trial of citicoline in acute ischemic stroke patients. Neurology 49:671-678, 1997
20. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE: A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 57:1595-1602, 2001
21. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 30:2592-2597, 1999
22. Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, et al: Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 380:349-357, 2012
23. Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, López S, et al: Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33:2850-2857, 2002
24. Davis SM, Albers GW, Diener HC, Lees KR, Norris J: Termination of acute stroke studies involving selfotel treatment. Lancet 349:32, 1997
25. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, et al: Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31:347-354, 2000
26. De Ryck M, Verhoye M, Van der Linden AM: Diffusionweighted MRI of infarct growth in a rat photochemical stroke model: effect of lubeluzole. Neuropharmacology 39:691-702, 2000
27. del Carmen Godino M, Romera VG, Sánchez-Tomero JA, Pacheco J, Canals S, Lerma J, et al: Amelioration of ischemic brain damage by peritoneal dialysis. J Clin Invest 123:4359-4363, 2013
28. del Zoppo GJ, Hallenbeck JM: Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98:73-81, 2000
29. del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, et al: Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 38 (2 Suppl):646-651, 2007
30. Diener HC: Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. Cerebrovasc Dis 8:172-181, 1998
31. Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, et al: Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 31:2543-2551, 2000
32. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-397, 1999
33. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D: Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev (11):CD000025, 2010
34. Dumitrascu OM, Lamb J, Lyden PD: Still cooling after all these years: Meta-analysis of pre-clinical trials of therapeutic hypothermia for acute ischemic stroke. J Cereb Blood Flow Metab 36:1157-1164, 2016
35. Edaravone Acute Infarction Study Group: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15:222-229, 2003
36. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al: Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40:e647-e656, 2009
37. Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J: Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis 21:79-85, 2006
38. Elting JW, Sulter GA, Kaste M, Lees KR, Diener HC, Hommel M, et al: AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels. Stroke 33:2813-2818, 2002
39. Enlimomab Acute Stroke Trial Investigators: Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57:1428-1434, 2001
40. Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, et al: Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 41:2283-2287, 2010
41. Feng S, Yang Q, Liu M, Li W, Yuan W, Zhang S, et al: Edaravone for acute ischaemic stroke. Cochrane Database Syst Rev (12):CD007230, 2011
42. Fraser JF: Standardisation of research strategies in acute ischaemic stroke. Lancet Neurol 15:784-785, 2016
43. Fu Y, Zhang N, Ren L, Yan Y, Sun N, Li YJ, et al: Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A 111:18315-18320, 2014
44. Galvin IM, Levy R, Boyd JG, Day AG, Wallace MC: Cooling for cerebral protection during brain surgery. Cochrane Database Syst Rev 1:CD006638, 2015
45. Gandolfo C, Sandercock P, Conti M: Lubeluzole for acute ischaemic stroke. Cochrane Database Syst Rev (1):CD001924, 2002
46. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, et al: Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40:1849-1857, 2009
47. Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJ: A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318:203-207, 1988
48. Ginsberg MD: Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40 (3 Suppl):S111-S114, 2009
49. Ginsberg MD: Expanding the concept of neuroprotection for acute ischemic stroke: the pivotal roles of reperfusion and the collateral circulation. Prog Neurobiol 145-146:46-77, 2016
50. Ginsberg MD: Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era. Stroke 38:1967-1972, 2007
51. Ginsberg MD: Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55:363-389, 2008
52. Ginsberg MD, Hill MD: Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy. Int J Stroke 10:494-500, 2015
53. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D: The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-I: Physiological responses and safety results. Stroke 37:2100-2106, 2006
54. Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, et al: The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke 42:119-127, 2011
55. Goslinga H, Eijzenbach V, Heuvelmans JH, van der Laan de Vries E, Melis VM, Schmid-Schönbein H, et al: Customtailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke 23:181-188, 1992
56. Grotta J: Lubeluzole treatment of acute ischemic stroke. Stroke 28:2338-2346, 1997
57. Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, et al: Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 26:602-605, 1995
58. Haley EC Jr, Thompson JL, Levin B, Davis S, Lees KR, Pittman JG, et al: Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies. Stroke 36:1006-1010, 2005
59. Hall ED: Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 134 Suppl:79-83, 1995
60. Heiss WD: The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. Cerebrovasc Dis 32:307-320, 2011
61. Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, et al: Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 11:942-950, 2012
62. Hong JM, Lee JS, Song HJ, Jeong HS, Choi HA, Lee K: Therapeutic hypothermia after recanalization in patients with acute ischemic stroke. Stroke 45:134-140, 2014 (Erratum in Stroke 45:e12, 2014)
63. Horn J, de Haan RJ, Vermeulen M, Limburg M: Very Early Nimodipine Use in Stroke (VENUS): a randomized, doubleblind, placebo-controlled trial. Stroke 32:461-465, 2001
64. Horn J, de Haan RJ, Vermeulen M, Luiten PG, Limburg M: Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 32:2433-2438, 2001
65. Horn J, Limburg M: Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev (2):CD001928, 2000
66. Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36:557-565, 1994
67. Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J: The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 41:607-616, 1997
68. Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, et al: A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis 26:105-111, 2007
69. Ikonomidou C, Turski L: Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1:383-386, 2002
70. Ishida K, Berger M, Nadler J, Warner DS: Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality. Curr Pharm Des 20:5751-5765, 2014
71. Ishikawa M, Zhang JH, Nanda A, Granger DN: Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci 9:1339-1347, 2004
72. Italian Acute Stroke Study Group: Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 1:318-321, 1988
73. Kaste M, Fogelholm R, Erilä T, Palomäki H, Murros K, Rissanen A, et al: A randomized, double-blind, placebocontrolled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 25:1348-1353, 1994
74. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:2160-2236, 2014
75. Khanna A, Walcott BP, Kahle KT, Simard JM: Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans. Neurosurg Focus 36(1):E11, 2014
76. Kohler E, Prentice DA, Bates TR, Hankey GJ, Claxton A, van Heerden J, et al: Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis. Stroke 44:2493-2499, 2013
77. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA: Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279, 276 in acute ischemic stroke. Stroke 34:2543-2548, 2003
78. Kubo T, Yamaguchi A, Iwata N, Yamashita T: The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther Clin Risk Manag 4:605-615, 2008
79. Kuroda S, Tsuchidate R, Smith ML, Maples KR, Siesjö BK: Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19:778-787, 1999
80. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al: A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490:187-191, 2012
81. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al: Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 355:1949-1954, 2000
82. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, et al: NXY-059 for acute ischemic stroke. N Engl J Med 354:588-600, 2006
83. Leng T, Shi Y, Xiong ZG, Sun D: Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke? Prog Neurobiol 115:189-209, 2014
84. Liao JK, Seto M, Noma K: Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50:17-24, 2007
85. Liesz A, Zhou W, Mracskó é, Karcher S, Bauer H, Schwarting S, et al: Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134:704-720, 2011
86. Lipton P: Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568, 1999
87. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622, 1994
88. Lisi M, Oelze M, Dragoni S, Liuni A, Steven S, Luca MC, et al: Chronic protection against ischemia and reperfusioninduced endothelial dysfunction during therapy with different organic nitrates. Clin Res Cardiol 101:453-459, 2012
89. Liu J, Wang LN, Ma X, Ji X: Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev 10:CD009622, 2016
90. Liu X, Wang L, Wen A, Yang J, Yan Y, Song Y, et al: Ginsenoside-Rd improves outcome of acute ischaemic stroke-a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol 19:855-863, 2012
91. Llovera G, Hofmann K, Roth S, Salas-Pérdomo A, Ferrer-Ferrer M, Perego C, et al: Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Sci Transl Med 7:299ra121, 2015
92. Llull L, Laredo C, Renú A, Pérez B, Vila E, Obach V, et al: Uric acid therapy improves clinical outcome in women with acute ischemic stroke. Stroke 46:2162-2167, 2015
93. Lodder J, van Raak L, Hilton A, Hardy E, Kessels A: Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. A randomized double-blind placebo-controlled trial. Cerebrovasc Dis 21:120-127, 2006
94. Love S: Oxidative stress in brain ischemia. Brain Pathol 9:119-131, 1999
95. Lund A, Lundby C, Olsen NV: High-dose erythropoietin for tissue protection. Eur J Clin Invest 44:1230-1238, 2014
96. Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, et al: Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 47:2888-2895, 2016
97. Lyden PD, Allgren RL, Ng K, Akins P, Meyer B, Al-Sanani F, et al: Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis 14:107-114, 2005
98. Marshall JW, Cross AJ, Ridley RM: Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species. Exp Neurol 156:121-129, 1999
99. Marshall JW, Duffin KJ, Green AR, Ridley RM: NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 32:190-198, 2001
100. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, et al: Correlation between myeloperoxidasequantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25:1469-1475, 1994
101. Mattson MP: Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44:625-633, 2009
102. Meldrum BS: Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130 (4S Suppl):1007S-1015S, 2000
103. Meloni BP, Zhu H, Knuckey NW: Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies. Magnes Res 19:123-137, 2006
104. Mergenthaler P, Dirnagl U, Meisel A: Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19:151-167, 2004
105. Minematsu K, Fisher M, Li L, Sotak CH: Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-d-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 24:2074-2081, 1993
106. Miyabe M, Kirsch JR, Nishikawa T, Koehler RC, Traystman RJ: Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats. Crit Care Med 25:1037-1043, 1997
107. Mohr JP, Orgogozo JM, Harrison MJG, Hennerici M, Wahlgren NG, Gelmers JH, et al: Meta-analysis of oral nimodipine trials in acute ischemic stroke. Cerebrovasc Dis 4:197-203, 1994
108. Montaner J, Bustamante A, García-Matas S, Martínez-Zabaleta M, Jiménez C, de la Torre J, et al: Combination of thrombolysis and statins in acute stroke is safe: results of the STARS Randomized Trial (Stroke Treatment with Acute Reperfusion and Simvastatin). Stroke 47:2870-2873, 2016
109. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al: Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:e38-e360, 2016
110. Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439-445, 2004
111. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA: Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140:471-476, 2003
112. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH: Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 39:3372-3377, 2008
113. Namura S, Nagata I, Takami S, Masayasu H, Kikuchi H: Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 32:1906-1911, 2001
114. Nimmagadda A, Park HP, Prado R, Ginsberg MD: Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laserscanning microscopy study. Stroke 39:198-204, 2008
115. O'Bryant Z, Vann KT, Xiong ZG: Translational strategies for neuroprotection in ischemic stroke-focusing on acidsensing ion channel 1a. Transl Stroke Res 5:59-68, 2014
116. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV: Toll-like receptors in neurodegeneration. Brain Res Brain Res Rev 59:278-292, 2009
117. Olney JW: Neurotoxicity of NMDA receptor antagonists: an overview. Psychopharmacol Bull 30:533-540, 1994
118. Onetti Y, Dantas AP, Pérez B, Cugota R, Chamorro A, Planas AM, et al: Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: a target of uric acid treatment. Am J Physiol Heart Circ Physiol 308:H862-H874, 2015
119. Park HP, Nimmagadda A, DeFazio RA, Busto R, Prado R, Ginsberg MD: Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study. Stroke 39:1556-1562, 2008
120. RANTTAS Investigators: A Randomized Trial of Tirilazad Mesylate in Patients with Acute Stroke (RANTTAS). Stroke 27:1453-1458, 1996
121. Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, et al: Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36:2251-2257, 2005
122. Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J: Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ 353:i1754, 2016
123. Romanos E, Planas AM, Amaro S, Chamorro A: Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 27:14-20, 2007
124. Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, et al: Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 285:1719-1728, 2001
125. Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, et al: Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 372:528-536, 2015
126. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analyses. Stroke 19:464-471, 1988
127. Schäbitz WR, Li F, Fisher M: The N-methyl-d-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke 31:1709-1714, 2000
128. Secades JJ, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Martínez-Vila E, Ríos J, et al: Citicoline for Acute Ischemic Stroke: a systematic review and formal meta-analysis of randomized, double-blind, and placebo-controlled trials. J Stroke Cerebrovasc Dis 25:1984-1996, 2016
129. Sena E, Wheble P, Sandercock P, Macleod M: Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke 38:388-394, 2007
130. Sheth KN, Elm JJ, Molyneaux BJ, Hinson H, Beslow LA, Sze GK, et al: Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 15:1160-1169, 2016
131. Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, et al: Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke 45:281-283, 2014
132. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E: Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 238:31-39, 2005
133. Shinohara Y, Saito I, Kobayashi S, Uchiyama S: Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial). Cerebrovasc Dis 27:485-492, 2009
134. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357:562-571, 2007
135. Siepmann T, Penzlin AI, Kepplinger J, Illigens BM, Weidner K, Reichmann H, et al: Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav 5:e00373, 2015
136. Spiotta AM, Chaudry MI, Hui FK, Turner RD, Kellogg RT, Turk AS: Evolution of thrombectomy approaches and devices for acute stroke: a technical review. J Neurointerv Surg 7:2-7, 2015
137. Stokum JA, Gerzanich V, Simard JM: Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab 36:513-538, 2016
138. Stoll G, Jander S, Schroeter M: Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171, 1998
139. Stroke Therapy Academic Industry Roundtable (STAIR): Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30:2752-2758, 1999
140. Sydserff SG, Cross AJ, Green AR: The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. Neurodegeneration 4:323-328, 1995
141. Tahir RA, Pabaney AH: Therapeutic hypothermia and ischemic stroke: a literature review. Surg Neurol Int 7 (Suppl 14):S381-S386, 2016
142. Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, et al: YM872: a selective, potent and highly water-soluble a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist. CNS Drug Rev 8:337-352, 2002
143. Teal P, Davis S, Hacke W, Kaste M, Lyden PD, Fierus M: A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/ pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT). Stroke 40:3518-3525, 2009
144. Tirilazad International Steering Committee: Tirilazad mesylate in acute ischemic stroke: a systematic review. Stroke 31:2257-2265, 2000
145. Tosun C, Kurland DB, Mehta R, Castellani RJ, deJong JL, Kwon MS, et al: Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke 44:3522-3528, 2013
146. Trust Study Group: Randomised, double-blind, placebocontrolled trial of nimodipine in acute stroke. Lancet 336:1205-1209, 1990
147. Turski L, Huth A, Sheardown M, McDonald F, Neuhaus R, Schneider HH, et al: ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A 95:10960-10965, 1998
148. van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, et al: EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke 9:642-645, 2014
149. Wahlgren NG, MacMahon DG, DeKeyser J, Indredavik B, Ryman T: Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 4:204-210, 1994
150. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, et al: Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 30:21-28, 1999
151. Walters MR, Kaste M, Lees KR, Diener HC, Hommel M, De Keyser J, et al: The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis 20:304-309, 2005
152. Wang Q, Tang XN, Yenari MA: The inflammatory response in stroke. J Neuroimmunol 184:53-68, 2007
153. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, et al: Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 48:713-722, 2000
154. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, et al: Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119-129, 2011
155. Westermaier T, Zausinger S, Baethmann A, Schmid-Elsaesser R: Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochir (Wien) 147:525-532, 2005
156. Willmot M, Gray L, Gibson C, Murphy S, Bath PM: A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12:141-149, 2005
157. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, et al: Ebselen in acute ischemic stroke: a placebocontrolled, double-blind clinical trial. Stroke 29:12-17, 1998
158. Yang Y, Li Q, Ahmad F, Shuaib A: Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett 285:119-122, 2000
159. Zhang E, Liao P: Brain transient receptor potential channels and stroke. J Neurosci Res 93:1165-1183, 2015
160. Zhang J, Yang J, Zhang C, Jiang X, Zhou H, Liu M: Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev (5):CD001928, 2012
161. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM, et al: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26:1438-1443, 1995